A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Trial Investigating the Efficacy and Safety of Clobetasol Propionate Cream, 0.025% in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days

Seemal Desai; Zoe Draelos; Steve Feldman; J. Mark Jackson

doi:10.25251/skin.5.supp.33

A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Trial Investigating the Efficacy and Safety of Clobetasol Propionate Cream, 0.025% in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.33 ◽

2021 ◽

Vol 5 (6) ◽

pp. s33

Author(s):

Seemal Desai ◽

Zoe Draelos ◽

Steve Feldman ◽

J. Mark Jackson

Keyword(s):

Plaque Psoriasis ◽

Clobetasol Propionate ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

N/A

Download Full-text

Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial

The Lancet Neurology ◽

10.1016/s1474-4422(11)70154-5 ◽

2011 ◽

Vol 10 (10) ◽

pp. 881-890 ◽

Cited By ~ 49

Author(s):

Patrick Kwan ◽

Martin J Brodie ◽

Reetta Kälviäinen ◽

Lorraine Yurkewicz ◽

Jerry Weaver ◽

...

Keyword(s):

Newly Diagnosed ◽

Efficacy And Safety ◽

Partial Seizures ◽

Phase 3 ◽

Double Blind ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

The Lancet ◽

10.1016/s0140-6736(18)31713-6 ◽

2018 ◽

Vol 392 (10148) ◽

pp. 650-661 ◽

Cited By ~ 139

Author(s):

Kenneth B Gordon ◽

Bruce Strober ◽

Mark Lebwohl ◽

Matthias Augustin ◽

Andrew Blauvelt ◽

...

Keyword(s):

Plaque Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Severe Plaque Psoriasis

Download Full-text

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2012.04716.x ◽

2012 ◽

Vol 27 (3) ◽

pp. e376-e383 ◽

Cited By ~ 67

Author(s):

K.A. Papp ◽

R. Kaufmann ◽

D. Thaçi ◽

C. Hu ◽

D. Sutherland ◽

...

Keyword(s):

Phase Ii ◽

Plaque Psoriasis ◽

Comparison Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Severe Plaque Psoriasis ◽

Dose Comparison ◽

Parallel Group

Download Full-text

Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil

BMC Neurology ◽

10.1186/1471-2377-13-99 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 7

Author(s):

Dagny Holle ◽

Jan Burmeister ◽

André Scherag ◽

Claudia Ose ◽

Hans-Christoph Diener ◽

...

Keyword(s):

Cluster Headache ◽

Prophylactic Treatment ◽

Oral Prednisone ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Episodic Cluster Headache ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs—a multicenter, double-blind, parallel-group trial

Modern Rheumatology ◽

10.3109/s10165-011-0425-8 ◽

2011 ◽

Vol 21 (5) ◽

pp. 458-468 ◽

Cited By ~ 13

Author(s):

Shinichi Kawai ◽

Tsutomu Takeuchi ◽

Kazuhiko Yamamoto ◽

Yoshiya Tanaka ◽

Nobuyuki Miyasaka

Keyword(s):

Rheumatoid Arthritis ◽

Early Rheumatoid Arthritis ◽

Inadequate Response ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Efficacy and safety results from a randomized, double-blind, vehicle-controlled study of clobetasol propionate spray for the treatment of moderate to severe plaque psoriasis of the scalp

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2009.11.538 ◽

2010 ◽

Vol 62 (3) ◽

pp. AB140

Keyword(s):

Plaque Psoriasis ◽

Clobetasol Propionate ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Severe Plaque Psoriasis

Download Full-text

Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Headache The Journal of Head and Face Pain ◽

10.1111/head.14169 ◽

2021 ◽

Author(s):

Fumihiko Sakai ◽

Norihiro Suzuki ◽

Byung‐Kun Kim ◽

Hisaka Igarashi ◽

Koichi Hirata ◽

...

Keyword(s):

Chronic Migraine ◽

Migraine Prevention ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Korean Patients ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

26197 Efficacy and safety of risankizumab vs methotrexate in patients with moderate-to-severe plaque psoriasis: Results from the 28-week randomized, double-blind period of an ongoing phase 3 study in Brazil

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.375 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB88

Author(s):

Tania F. Cestari ◽

Cacilda daSilva Souza ◽

Luna Azulay-Abulafia ◽

Ricardo Romiti ◽

André V.E. Carvalho ◽

...

Keyword(s):

Plaque Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Ongoing Phase

Download Full-text

Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.13746 ◽

2016 ◽

Vol 31 (1) ◽

pp. 89-95 ◽

Cited By ~ 36

Author(s):

L. Cai ◽

J. Gu ◽

J. Zheng ◽

M. Zheng ◽

G. Wang ◽

...

Keyword(s):

Plaque Psoriasis ◽

Blind Study ◽

Chinese Patients ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Severe Plaque Psoriasis

Download Full-text

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

Current Therapeutic Research ◽

10.1016/j.curtheres.2009.11.001 ◽

2009 ◽

Vol 70 (6) ◽

pp. 405-420 ◽

Cited By ~ 19

Author(s):

Franklin Chu ◽

Neila Smith ◽

Takeshi Uchida

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Multicenter Phase ◽

Solifenacin Succinate ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text